Monoclonal antibodies in cancer treatment: where do we stand after 10 years?

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Radiotherapy and Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0167-8140(86)80165-7PMID 3517970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting

  2004cited by this paper
• Selective cytotoxicity of 125I-labeled monoclonal antibody T101 in human malignant T cell lines.

  1986cited by this paper
• Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody.

  1985cited by this paper
• Heterogeneity and clonal variation related to cell surface expression of a mouse lung tumor-associated antigen quantified using flow cytometry.

  1984cited by this paper
• Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia.

  1984cited by this paper
• Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts.

  1984cited by this paper
• Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.

  1984cited by this paper
• Imaging of T-cell lymphoma by radiolabelled monoclonal antibody.

  1984cited by this paper
• Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess.

  1984cited by this paper
• Diagnostic and therapeutic use of monoclonal antibodies to human tumor antigens

  1984cited by this paper
• Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.

  1984cited by this paper
• Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.

  1984cited by this paper
• Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells.

  1984cited by this paper
• Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101.

  1984cited by this paper
• Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?

  1984cited by this paper
• A chlorambucil-anti-CEA conjugate cytotoxic for human colon adenocarcinoma cells in vitro.

  1984cited by this paper
• Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration.

  1984cited by this paper
• An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A.

  1984cited by this paper
• Monoclonal antibodies to breast cancer‐associated antigens as potential reagents in the management of breast cancer

  1984cited by this paper
• Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments.

  1984cited by this paper
• Antigen expression in human melanoma cells in relation to growth conditions and cell‐cycle distribution

  1984cited by this paper
• High-level iodination of monoclonal antibody fragments for radiotherapy.

  1984cited by this paper
• Lymphokines, monoclonal antibodies, and other biological response modifiers in the treatment of cancer

  1984cited by this paper
• T65 antigen modulation in a phase I monoclonal antibody trial with chronic lymphocytic leukemia patients.

  1984cited by this paper
• The detection of ovarian cancer using 123J monoclonal antibody.

  1984cited by this paper
• Immunoscintigraphy of colon carcinoma.

  1984cited by this paper
• Immunoscintigraphy for detection of lymph node metastases from breast cancer.

  1984cited by this paper
• Therapeutic applications of Auger and alpha emitting radionuclides.

  1984cited by this paper
• Monoclonal antibodies: the possibilities for cancer therapy.

  1984cited by this paper
• An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A

  1984cited by this paper
• Monoclonal antibodies in cancer therapy.

  1983cited by this paper
• Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells.

  1983cited by this paper
• Immunoassays for clinical chemistry

  1983cited by this paper
• Production of a monoclonal antibody-bleomycin conjugate utilizing dextran T-40 and the antigen-targeting cytotoxicity of the conjugate.

  1983cited by this paper
• Dosimetry of 131I-labeled antiferritin in hepatoma: specific activities in the tumor and liver.

  1983cited by this paper
• Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.

  1983cited by this paper
• Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy.

  1983cited by this paper
• Ricin A-chain conjugated with monoclonal anti-L1210 antibody

  1983cited by this paper
• Improved tumour localisation using indium-111 labelled antibodies.

  1983cited by this paper
• Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugate.

  1983cited by this paper
• Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth.

  1983cited by this paper
• Preparation and properties of a drug‐carrier‐antibody conjugate showing selective antibody‐directed cytotoxicity in vitro

  1983cited by this paper
• Radioactive labeling of antibody: a simple and efficient method.

  1983cited by this paper
• Therapeutic use of human monoclonal antibodies.

  1983cited by this paper
• Differential binding to human mammary and nonmammary tumors of monoclonal antibodies reactive with carcinoembryonic antigen.

  1983cited by this paper
• Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation.

  1983cited by this paper
• Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies.

  1983cited by this paper
• Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer.

  1983cited by this paper
• The production of monoclonal antibodies from human lymphocytes.

  1983cited by this paper
• Heterogeneity of HLA-A,B, Ia-like, and Melanom Expression by Human Melanoma Cell Lines Analyzed with Monoclonal Antibodies and Flow Cytometry

  1982cited by this paper
• Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen.

  1982cited by this paper
• Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies.

  1982cited by this paper
• Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody–ricin conjugate

  1982cited by this paper
• The in vivo fate of a 211At labelled monoclonal antibody with known specificity in a murine system.

  1982cited by this paper
• Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.

  1982cited by this paper
• A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.

  1982cited by this paper
• Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.

  1982cited by this paper
• Monoclonal antibodies: potential role in radiation therapy and oncology.

  1982cited by this paper
• Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma.

  1982cited by this paper
• Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours.

  1982cited by this paper
• IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.

  1982cited by this paper
• Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody.

  1982cited by this paper
• Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells

  1981cited by this paper
• Serotherapy of acute lymphoblastic leukemia with monoclonal antibody.

  1981cited by this paper
• Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody.

  1981cited by this paper
• Fate of a common acute lymphoblastic leukemia antigen during modulation by monoclonal antibody.

  1981cited by this paper
• Human T-cell antigens defined by monoclonal antibodies. Absence of T65 on committed myeloid and erythroid progenitors

  1980cited by this paper
• Human T-cell antigens defined by monoclonal antibodies. Absence of T65 on committed myeloid and erythroid progenitors.

  1980cited by this paper
• Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen.

  1980cited by this paper
• Radioimmunodetection of primary and metastatic ovarian cancer using radiolabeled antibodies to carcinoembryonic antigen.

  1980cited by this paper
• The effect in vivo of chemotherapeutic drug—antibody conjugates in two murine experimental tumor systems

  1978cited by this paper
• The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities.

  1975cited by this paper
• Prediction of local recurrence in colorectal carcinoma: an LDH isoenzymatic assay.

  1975cited by this paper
• Continuous cultures of fused cells secreting antibody of predefined specificity

  1975cited by this paper

• Gamma knife surgery for patients with volumetric classification of nonfunctioning pituitary adenomas: a systematic review and meta-analysis.

  2013cites this paper
• Risks and untoward toxicities of antibody-based immunoconjugates.

  2012cites this paper
• Preclinical models and methods for the study of radiolabeled monoclonal antibodies in cancer diagnosis and therapy.

  1990cites this paper
• The biological approach to radioimmunoscitigraphy

  1990cites this paper
• Human IgM monoclonal antibody 16.88: pharmacokinetics and distribution in mouse and man.

  1990cites this paper
• The biological approach to radioimmunoscintigraphy.

  1990cites this paper
• Patents and literature

  1988cites this paper
• Monoclonal antibodies and immobilized antibodies

  1987cites this paper
• Monoclonal antibodies and immobilized antibodies. Patents and literature.

  1987cites this paper
• Optimal dose distribution for eradication of heterogeneous tumours.

  1987cites this paper
• Monoclonal Antibodies in the Management of Breast Cancer

  1986cites this paper